Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001951018 | SCV002238845 | pathogenic | not provided | 2021-02-03 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with MSH3-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Thr981Asnfs*5) in the MSH3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MSH3 are known to be pathogenic (PMID: 27476653). |
Myriad Genetics, |
RCV004044378 | SCV004930913 | pathogenic | Familial adenomatous polyposis 4 | 2024-02-07 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |